Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of riluzole, riluzole prodrugs or riluzole analogs with immunotherapies to treat cancers

Use of riluzole, riluzole prodrugs or riluzole analogs with immunotherapies to treat cancers

US Patent 11400155 · Granted Aug 2, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of glutamate modulating agents with immunotherapies to treat cancer2025
Use of riluzole oral disintegrating tablets for treating diseases2025
Use of riluzole prodrugs to treat Alzheimer's disease2025
Use of riluzole prodrugs to treat alzheimer's disease2024
Sublingual formulation of riluzole2024
Use of riluzole prodrugs to treat ataxias2024
Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treat2024
Sublingual formulation of riluzole2023
Glutamate agents in the treatment of mental disorders2023
Rimegepant for CGRP related disorders2021
Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treat2020
Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treat2019